Tert-butyl [4-[1-[3-(4-carbamoyl-3-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethoxy]piperidin-1-yl] carbonate
C21H27FN4O6 — CID 70376020
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl [4-[1-[3-(4-carbamoyl-3-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethoxy]piperidin-1-yl] carbonate
Tert-butyl [4-[1-[3-(4-carbamoyl-3-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethoxy]piperidin-1-yl] carbonate (PubChem CID 70376020) has the molecular formula C21H27FN4O6 and a molecular weight of 450.47 g/mol. Its IUPAC name is tert-butyl [4-[1-[3-(4-carbamoyl-3-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethoxy]piperidin-1-yl] carbonate.
Molecular Properties
| Compound Name | Tert-butyl [4-[1-[3-(4-carbamoyl-3-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethoxy]piperidin-1-yl] carbonate |
|---|---|
| PubChem CID | 70376020 |
| Molecular Formula | C21H27FN4O6 |
| Molecular Weight | 450.47 g/mol |
| Exact Mass | 450.19 |
| IUPAC Name | tert-butyl [4-[1-[3-(4-carbamoyl-3-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethoxy]piperidin-1-yl] carbonate |
| SMILES | CC(OC1CCN(OC(=O)OC(C)(C)C)CC1)c1nc(-c2ccc(C(N)=O)c(F)c2)no1 |
| InChI | InChI=1S/C21H27FN4O6/c1-12(29-14-7-9-26(10-8-14)32-20(28)30-21(2,3)4)19-24-18(25-31-19)13-5-6-15(17(23)27)16(22)11-13/h5-6,11-12,14H,7-10H2,1-4H3,(H2,23,27) |
| InChIKey | IGNKJPTXJFGMFY-UHFFFAOYSA-N |
| XLogP | 3.38 |
| TPSA | 130.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.47 |
| LogP ≤ 5 | 3.38 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70376020 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.